Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
NCT04684602
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This multi-arm, multi-site study investigates the safety, tolerability, and efficacy of stem cell therapy for the treatment of various acute and chronic conditions. Clinically observed initial findings and an extensive body of research indicate regenerative treatments are both safe and effective for the treatment of multiple conditions.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Autoimmune Diseases
- Cardiovascular Disorders
- Diabetes Complications
- Integumentary Disease
- Musculoskeletal Disorders
- Neurodegenerative Disorders
- Neurologic Disorders
- Pulmonary Disorders
- Sexual Dysfunction
- Urologic Disorders
- Viral Illness
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1/2
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Thomas Advanced Medical LLC
- Last updated on ClinicalTrials.gov
- April 29, 2022
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites · Culver City, CA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.